Boy, 12, who has autism spectrum disorder, claims there was a failure to inform his mother of the risks associated with the drug Epilim

Patients urged not to stop taking valproate without consulting their doctors

The boy’s younger brother has also settled his High Court action while his older sister has a case pending

Valproate or sodium valproate is an ingredient in a drug sold as Epilim manufactured by Sanofi which is used for the treatment of epilepsy and also for bi-polar disorder and other conditions.

The advice from Ireland's Health Products Regulatory Authority not to discontinue the treatment comes in the wake of new recommendations in the UK

It is now accepted babies exposed to valproate in the womb have a 10% risk of birth defects and a 30%-40% risk of neuro-developmental disabilities which can be permanent.

Teenager settles High Court case regarding epilepsy drug Epilim (sodium valproate) that his mother had taken when she was pregnant

Teenager claimed two doctors failed to properly inform his mother about the risks of taking Epilim

A teenager with developmental delay and autism is suing a general practitioner and a neurologist alleging they failed to properly inform his mother about the risks of taking certain epilepsy drugs while pregnant.

Solicitor for 20 families affected by sodium valproate prescribing scandal says they should not be forced through the 'distress' of court

Briefings prepared for Health Minister Stephen Donnelly indicate that warnings about using anti-epilepsy drug during pregnancy were not acted on

1,250 people  living with serious harm which can be caused by a prescription epilepsy drug, Epilim, containing sodium valproate, when it is taken by pregnant women